Sunshine Biopharma (SBFM) Receivables - Other (2018)
Sunshine Biopharma's (SBFM) quarterly Receivables - Other came in at $51000.0 in Q2 2018.
Sunshine Biopharma (SBFM) Receivables - Other (2018) Analysis & Trends
Sunshine Biopharma (SBFM) has 1 years of Receivables - Other data on file, last reported at $51000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.08 Bn | 2.15 Bn |
| 3 | Zoetis | 32.22 Bn | 30.55 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Sunshine Biopharma | 1.57 Mn | -12.18 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 51,000.00 |
| Jun 30, 2018 | 51,000.00 |